Evidence map›Paper›PMID 37398830›Full record

ArticleCureus2023

Primary Colorectal Tumor Location and Predictors for Metastasis to the Brain.

William Franceschi, Jonathan Bliggenstorfer, Anuja L Sarode, Meridith Ginesi, Emily Steinhagen, Sharon L Stein

Abstract read
In one paragraph

Article in Cureus, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Identification of a gene expression signature associated with brain metastasis in colorectal cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

William FranceschiDepartment of General Surgery, Case Western Reserve University School of Medicine, Cleveland, USA.
Jonathan BliggenstorferDepartment of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.
Anuja L SarodeDepartment of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.
Meridith GinesiDepartment of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.
Emily SteinhagenDepartment of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.
Sharon L SteinDepartment of Surgery, University Hospitals Cleveland Medical Center - University Hospitals Research in Surgical Outcomes & Effectiveness Center (UH-RISES), Cleveland, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction Although rectal cancer is thought to have a higher rate of metastasis to the brain compared with colon cancer, there is limited and contradictory data on the subject. This study aims to determine the prevalence of brain metastasis for colon and rectal cancers (CRC), and to explore associations and predictors of brain metastasis (BM). Methods The 2010-2016 National Cancer Database (NCDB) was queried for patients with stage IV CRC. Patients with missing data on site of metastasis and primary tumor location were excluded. Chi-square test was used for categorical data and multivariate logistic regression analysis was performed to evaluate the predictors of BM. Results Of 108,540 stage IV CRC patients, the prevalence of BM was 1.21% from the right colon, 1.29% from the left colon, and 1.59% from the rectal adenocarcinoma (p<0.001). The presence of lung, bone, and liver metastases were the strongest predictors for BM. Bone and lung metastases increased the odds for BM by 3.87 (95% CI: 3.36-4.46) and 3.38 (95% CI: 3.01-3.80), respectively while the presence of liver metastasis decreased odds for BM by 55% (OR: 0.45; 95% CI: 0.40-0.50). On multivariate analysis, primary tumor location was not predictive of BM. Discussion This study helps to characterize the prevalence and associations of BM from CRC using the NCDB. The correlation between BM and bone and lung metastases, along with negative association of liver metastasis further supports the hypothesis of systemic transmission of tumor cells. Further identification of predictors and correlations with BM may help guide surveillance among patients with advanced CRC.

Indexed as

adenocarcinoma of colonbrain tumors (primary or brain metastasis)colorectal cancermetastatic brain tumorsmetastatic colo-rectal cancerpredictors of metastasis

Identifiers

PMID37398830
PMCPMC10310402

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.